+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Latent Tuberculosis Infection (LTBI) Testing Market Report: Insights, Trends & Forecast (2019-2023)

  • ID: 4804138
  • Report
  • July 2019
  • Region: Global
  • 106 Pages
  • Koncept Analytics
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Latent Tuberculosis Infection (LTBI) Testing Market is Estimated to Reach US$2.1 Billion in 2023, Growing at a CAGR of 5.59%

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • BioMerieux
  • Qiagen
  • Roche Holding AG
  • MORE

The factors such as rapid tuberculosis prevalence, increased tuberculosis awareness, rising prevalence of HIV and increasing government initiatives are expected to drive the market growth. However, growth of the industry will be challenged by multidrug-resistant tuberculosis, lack of laboratory facilities and lack of awareness in emerging markets. A few notable trends include increasing government initiatives, increasing healthcare expenditure in emerging countries and advanced and hybrid technologies.

The latent tuberculosis infection testing market comprises two main segments namely the Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). TST being a traditional test for tuberculosis diagnosis is the most recommended test. In the global latent tuberculosis testing market, the tuberculin skin test segment accounted for the higher share in 2018.

The fastest-growing regional market in the U.S. due to increasing public awareness and increasing healthcare expenditure on diagnosis and treatment in developing countries. The U.S. represents one of the largest markets for LTBI testing and is already well-penetrated at developed market levels. China, Japan and Europe and the Middle East are emerging markets where growth lies in government expenditure on disease-related initiatives and technological developments.

Scope of the report:

  • The report provides a comprehensive analysis of the global latent tuberculosis infection (LTBI) testing market, segmented into the Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA) segments.
  • The major regional markets (Europe and the Middle East, Asia Pacific (Excluding Japan and China) and Latin America) have been analyzed, along with country coverage of US, China and Japan.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Qiagen, Abbott, Becton Dickinson, Biomerieux, Roche and Thermo Fisher Scientific) are also presented in detail.

Key Target Audience:

  • Latent Tuberculosis Infection (LTBI) Testing Devices Manufacturers
  • Raw Material/Component Suppliers
  • End Users (Physician Offices, Hospitals, Healthcare Clinics)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Please note: 10% free customization equates to up to 3 hours of analyst time. 
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • BioMerieux
  • Qiagen
  • Roche Holding AG
  • MORE

1. Market Overview
1.1 Tuberculosis (TB)
1.2 Types of Tuberculosis (TB)
1.3 Latent Tuberculosis Infection (LTBI)
1.4 Risk Factors of Latent Tuberculosis
1.5 Types of Latent Tuberculosis Infection Testing
1.6 Latent Tuberculosis Infection Testing Segmentation

2. Global LTBI Testing Market
2.1 Global LTBI Testing Market Forecast by Value
2.2 Global LTBI Testing Market Value by Region
2.3 Global LTBI Testing Market Forecast by Volume
2.4 Global LTBI Testing Market Volume by Region
2.5 Global LTBI Testing Market Volume by Segment
2.5.1 Global IGRA Testing Market Forecast by Volume
2.5.2 Global TST Market Forecast by Volume

3. Regional LTBI Testing Market
3.1 The U.S.
3.1.1 The U.S. LTBI Testing Market Forecast by Value
3.1.2 The U.S. LTBI Testing Market Forecast by Volume
3.1.3 The U.S. LTBI Testing Market by End User
3.2 China
3.2.1 China LTBI Testing Market Forecast by Value
3.2.2 China LTBI Testing Market Forecast by Volume
3.3 Asia-Pacific (Excluding Japan and China)
3.3.1 Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Value
3.3.2 Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Volume
3.4 Latin America
3.4.1 Latin America LTBI Testing Market Forecast by Value
3.4.2 Latin America LTBI Testing Market Forecast by Volume
3.5 Japan
3.5.1 Japan LTBI Testing Market Forecast by Value
3.5.2 Japan LTBI Testing Market Forecast by Volume
3.6 Europe and the Middle East
3.6.1 Europe and the Middle East LTBI Testing Market Forecast by Value
3.6.2 Europe and the Middle East LTBI Testing Market Forecast by Volume

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Awareness of Tuberculosis
4.1.2 Rising Geriatric Population
4.1.3 Declining Tobacco Price
4.1.4 Increasing Tuberculosis Detection Rate
4.1.5 Upsurge in Cigarette Consumption
4.1.6 Growing Urban Population
4.1.7 Rising Prevalence of HIV
4.2 Key Trends & Developments
4.2.1 Increasing Government Initiatives
4.2.2 Increasing Healthcare Expenditure in Emerging Markets
4.2.3 Expansion of Advanced and Hybrid Technique
4.2.4 Line Probe Assays (LPAs)
4.2.5 Nucleic Acid Amplification Tests (NAATs)
4.3 Challenges
4.3.1 Stringent Government Regulations
4.3.2 Multidrug-Resistant Tuberculosis (MDR-TB)
4.3.3 Lack of Awareness in Emerging market
4.3.4 Lack of Laboratory Facilities

5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players
5.1.3 R&D Comparison of Key Players

6. Company Profiles
6.1 Qiagen
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Abbott
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Becton Dickinson
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 BioMerieux
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Roche Holding AG
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
6.6 Thermo Fisher Scientific Inc
6.6.1 Business Overview
6.6.2 Financial Overview
6.6.3 Business Strategies

List of Figures

  • Symptoms of TB
  • Types of TB
  • Differences between Latent TB and Active TB
  • Risk Factors of Latent Tuberculosis
  • Types of Latent Tuberculosis Infection Testing
  • Latent Tuberculosis Infection Testing Segmentation
  • Global LTBI Testing Market Forecast by Value (2018-2023)
  • Global LTBI Testing Market Value by Region (2018)
  • Global LTBI Testing Market Forecast by Volume (2018-2023)
  • Global LTBI Testing Market Volume by Region (2018)
  • Global LTBI Testing Market Volume by Segments (2018)
  • Global IGRA Test Market Forecast by Volume (2018-2023)
  • Global TST Market Forecast by Volume (2018-2023)
  • The U.S. LTBI Testing Market Forecast by Value (2018-2023)
  • The U.S. LTBI Testing Market Forecast by Volume (2018-2023)
  • The US LTBI Testing Market by End User (2018)
  • China LTBI Testing Market Forecast by Value (2018-2023)
  • China LTBI Testing Market Forecast by Volume (2018-2023)
  • Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Value (2018-2023)
  • Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Volume (2018-2023)
  • Latin America LTBI Testing Market Forecast by Value (2018-2023)
  • Latin America LTBI Testing Market Forecast by Volume (2018-2023)
  • Japan LTBI Testing Market Forecast by Value (2018-2023)
  • Japan LTBI Testing Market Forecast by Volume (2018-2023)
  • Europe and the Middle East LTBI Testing Market Forecast by Value (2018-2023)
  • Europe and the Middle East Mark LTBI Testing Market Forecast by Volume (2018-2023)
  • Global Literacy Rate (2014-2018)
  • Global Geriatric Population (2014-2018)
  • Global Tobacco Price (2013-2021)
  • Global Tuberculosis Case Detection Rate (2014-2018)
  • Global Cigarette Consumption (2014-2020)
  • Global Urban Population (2014-2019)
  • Global HIV Population (2014-2018)
  • Global Healthcare Expenditure (1995-2022)
  • Revenue Comparison of Key Players (2018)
  • Market Cap Comparison of Key Players (2018)
  • R&D Comparison of Key Players (2017-2018)
  • Qiagen Net Sales and Net Income (2014-2018)
  • Qiagen Net Sales by Segment (2018)
  • Qiagen Net Sales by Region (2018)
  • Abbott Net Sales and Net Earnings (2014-2018)
  • Abbott Net Sales by Segment (2018)
  • Abbott Net Sales by Region (2018)
  • Becton Dickinson Revenue and Net Income (2014-2018)
  • Becton Dickinson Revenue by Segment (2018)
  • Becton Dickinson Revenue by Region (2018)
  • BioMerieux Sales and Net Income (2014-2018)
  • BioMerieux Sales by Segment (2018)
  • BioMerieux Sales by Region (2018)
  • Roche Holding AG Revenue and Net Income (2014-2018)
  • Roche Holding AG Revenue by Segment (2018)
  • Roche Holding AG Revenue by Region (2018)
  • Thermo Fisher Scientific Revenue and Net Income (2014-2018)
  • Thermo Fisher Scientific Revenue by Segment (2018)
  • Thermo Fisher Scientific Revenue by Region (2018)

List of Tables

  • Current LPA products and Associated Equipment
  • NAAT-based Technologies
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Becton Dickinson
  • BioMerieux
  • Qiagen
  • Roche Holding AG
  • Thermo Fisher Scientific Inc
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll